EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advi...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of hepatology Ročník 69; číslo 1; s. 182 - 236
Hlavní autori: Galle, Peter R., Forner, Alejandro, Llovet, Josep M., Mazzaferro, Vincenzo, Piscaglia, Fabio, Raoul, Jean-Luc, Schirmacher, Peter, Vilgrain, Valérie
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Netherlands Elsevier B.V 01.07.2018
Elsevier Science Ltd
Predmet:
Carcinoma, Hepatocellular - therapy
Clinical medicine
Clinical practice guidelines
Decision making
Disease Management
Europe
Gastroenterology
Hepatocellular carcinoma
Humans
Liver cancer
Liver Neoplasms - therapy
Practice Guidelines as Topic
Societies, Medical
Europe
ISSN:0168-8278, 1600-0641, 1600-0641
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0168-8278
1600-0641
1600-0641
DOI:10.1016/j.jhep.2018.03.019